2017 BEST PRACTICEs CONFERENCES SERIES - BOOK YOUR PLACE TODAY!
EUROPE, Middle EAST & AFRICASTARTS IN:
NORTH and south americasSTARTS IN:
ORLANDO, FL USA
asia pacificSTARTS IN:
KOTA KINABALU, MALAYSIA
News : Coimbatore Hospital Launches Breast Cancer Helpline
Coimebatore, India, Oct 1, 2015 -- Women who now notice new lumps in and around their breasts but hesitate to approach a doctor might now call 1800-2700-703. This is a toll free helpline number set up by Sri Ramakrishna Institute of Oncology and Research (SRIOR) to exclusively cater to queries related to breast cancer.
They say this number is targeted towards the millions of women living in rural pockets who hesitate to approach a male doctor with this problem or scared to even inform their families.
The toll free number, which can be rung up from any nook and corner of the country, will educate the caller about the various stages of breast cancer, risks of it, signs and symptoms, importance of early detection, diagnostic tests required to check the lumps, treatment options available, side-effects of chemotherapy, dietary tips and how breast cancer might be prevented.
"It also has a provision where they can leave a message for me with their email ids. I would be able to listen to all the messages and reply to them maybe once or twice a day," said director and chief oncologist at SRIOR, Dr P Guhan.
"We will be mainly directing them on how to do a more clinical examination at home, doctors and hospitals they can approach in their vicinity and doubts regarding treatment itself," he said.
"A lot of women in villages hesitate to allow a clinical examination of their breasts by a male doctor, who might be the only doctor in their village. So they might prefer listening to a recorded automatic voice that will guide them on their future course of action," he said.
The helpline will function in both English and Tamil, so as to cater to as many women in Tamil Nadu as possible.
Posted by Veronica Silva Cusi, news correspondent
Today's Tip of the Day - Customer Satisfaction
More Editorial From Sri Ramakrishna Institute of Oncology and Research
Published: Monday, October 5, 2015